Michelle J. Cox

WinnMed — United States

Medicine · Health Sciences

12h-index1.2kcitations109works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(90), Phagocytosis and Immune Regulation(35), Virus-based gene therapy research(14), Chronic Lymphocytic Leukemia Research(9), Immune Cell Function and Interaction(8)

Publications109 total

Haplogroup Poster References
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
Haplogroup Poster References
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
Supplementary Table S1 from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025Open Access
Supplementary Figure Legends from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025Open Access
Supplementary Figures from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025Open Access
Supplementary Table S2 from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025Open Access
OC56 Anaemia and red blood cell transfusion in paediatric liver transplantation: a retrospective observational study
2025
Supplementary Figure Legends from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Figure Legends from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Table S1 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Figures from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Table S1 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Table S2 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Table S2 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Supplementary Figures from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
Data from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024Open Access
IL-4 drives exhaustion of CD8+ CART cells
Nature Communications·2024· 28 citedOpen Access
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression
Nature Biomedical Engineering·2024· 30 citedOpen Access
Attentional bias effects following trauma exposure: comparison of emotional Stroop and emotional lexical decision task paradigms
Swinburne Research Bank (Swinburne University of Technology)·2024Open Access
The Identification of IL-4 as a Regulator of Chimeric Antigen Receptor T Cell Exhaustion
2023· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Saad S. Kenderian(49), Reona Sakemura(48), Mehrdad Hefazi(39), Kendall J. Schick(36), Neil E. Kay(32), Elizabeth L. Siegler(30), Claudia Manriquez Roman(30), Michael W. Ruff(29), Erin E. Tapper(28), Sameer A. Parikh(26), İsmail Can(25), Paulina Horvei(21), Michael J. Hansen(18), Lionel Aurelien Kankeu Fonkoua(18), Carli M. Stewart(18), Evandro D. Bezerra(16), Mohamad M. Adada(15), Ekene J. Ogbodo(14), Wendy K. Nevala(11), Justin C. Boysen(11)